Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Christensen

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Expert Review of Vaccines|July 26, 2012
Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical statusKaren Smith Korsholm, Peter Lawætz Andersen, Dennis Christensen
Pain|June 28, 2001
Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic painDennis Christensen, Michèle Gautron, Gisèle Guilbaud, et al.
ILAR Journal|January 10, 2019
Rational Design and In Vivo Characterization of Vaccine AdjuvantsSigne Tandrup Schmidt, Gabriel Kristian Pedersen, Dennis Christensen
Molecular Pharmaceutics|August 23, 2019
Scale-Independent Microfluidic Production of Cationic Liposomal Adjuvants and Development of Enhanced Lymphatic Targeting StrategiesCarla B Roces, Swapnil Khadke, Dennis Christensen, et al.
Frontiers in Immunology|October 19, 2020
Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center ResponsesGabriel Kristian Pedersen, Katharina Wørzner, Peter Andersen, et al.
Journal of Molecular Modeling|March 5, 2020
Models for predicting impact sensitivity of energetic materials based on the trigger linkage hypothesis and Arrhenius kineticsTomas L Jensen, John F Moxnes, Erik Unneberg, et al.
Expert Review of Vaccines|April 22, 2011
Cationic liposomes as vaccine adjuvantsDennis Christensen, Karen Smith Korsholm, Peter Andersen, et al.
Vaccine|October 24, 2015
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulationGennaro Prota, Dennis Christensen, Peter Andersen, et al.
International Journal of Pharmaceutics|November 6, 2023
Reconstituted dry powder formulations of ZnO-adjuvanted ovalbumin induce equivalent antigen specific antibodies but lower T cell responses than ovalbumin adjuvanted with Alhydrogel® or cationic adjuvant formulation 01 (CAF®01)Marie Hellfritzsch, Dennis Christensen, Camilla Foged, et al.
Plos One|May 28, 2010
Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge modelAnja Weinreich Olsen, Michael Theisen, Dennis Christensen, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Expert Review of Vaccines|July 26, 2012
Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical statusKaren Smith Korsholm, Peter Lawætz Andersen, Dennis Christensen
Pain|June 28, 2001
Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic painDennis Christensen, Michèle Gautron, Gisèle Guilbaud, et al.
ILAR Journal|January 10, 2019
Rational Design and In Vivo Characterization of Vaccine AdjuvantsSigne Tandrup Schmidt, Gabriel Kristian Pedersen, Dennis Christensen
Molecular Pharmaceutics|August 23, 2019
Scale-Independent Microfluidic Production of Cationic Liposomal Adjuvants and Development of Enhanced Lymphatic Targeting StrategiesCarla B Roces, Swapnil Khadke, Dennis Christensen, et al.
Frontiers in Immunology|October 19, 2020
Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center ResponsesGabriel Kristian Pedersen, Katharina Wørzner, Peter Andersen, et al.
Journal of Molecular Modeling|March 5, 2020
Models for predicting impact sensitivity of energetic materials based on the trigger linkage hypothesis and Arrhenius kineticsTomas L Jensen, John F Moxnes, Erik Unneberg, et al.
Expert Review of Vaccines|April 22, 2011
Cationic liposomes as vaccine adjuvantsDennis Christensen, Karen Smith Korsholm, Peter Andersen, et al.
Vaccine|October 24, 2015
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulationGennaro Prota, Dennis Christensen, Peter Andersen, et al.
International Journal of Pharmaceutics|November 6, 2023
Reconstituted dry powder formulations of ZnO-adjuvanted ovalbumin induce equivalent antigen specific antibodies but lower T cell responses than ovalbumin adjuvanted with Alhydrogel® or cationic adjuvant formulation 01 (CAF®01)Marie Hellfritzsch, Dennis Christensen, Camilla Foged, et al.
Plos One|May 28, 2010
Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge modelAnja Weinreich Olsen, Michael Theisen, Dennis Christensen, et al.
Pageof 15